News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
The 2024 DF/HCC Breast Cancer Program Research Retreat – Dana-Farber’s Breast Oncology Center
Photo taken from Dana-Farber’s Breast Oncology Center/X
Sep 2, 2024, 07:17

The 2024 DF/HCC Breast Cancer Program Research Retreat – Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X:

“Register today for the 2024 Dana-Farber/Harvard Cancer Center (DF/HCC) Breast Cancer Program Research Retreat titled AI-Driven Cancer Solutions: From Basic Science to Standard of Care in Breast Cancer & Beyond.

Fri Sept 20th, 12:00-6:00pm  Starr Center, MGH, 185 Cambridge St, Boston.”

Image
2024 DF/HCC artificial intelligence Breast Cancer cancer Dana-Farber Dana-Farber’s Breast Oncology Center Harvard Medical School OncoDaily Oncology
Special Coverage
Blog
Sep 2, 2024, 07:17
The 2024 DF/HCC Breast Cancer Program Research Retreat - Dana-Farber’s Breast Oncology Center
Blog
Sep 2, 2024, 07:14
Matt Yurgelun: I’ll be walking to raise money for the Dana Farber Lynch Syndrome Center
Insight
Sep 2, 2024, 07:05
Samuel Bakhoum: The role of mitochondria and free radicals in promoting the collapse of cancer micronuclei
Blog
Sep 2, 2024, 07:02
Colton Ladbury received 2024 ASTRO Annual Meeting Abstract Recognition Award
Blog
Sep 2, 2024, 07:00
The connection between a new class of weight loss drugs and cancer risk reduction - MSKCC
Societies
Sep 2, 2024, 06:54
The beginning of Gold September - SIOP Europe
Societies
Sep 2, 2024, 06:48
American Society of Clinical Oncology (ASCO)'s Medical Education Community of Practice TOWN HALL
Insight
Sep 2, 2024, 04:06
23rd Annual Hispanic Women of Distinction Charity Luncheon
Insight
Sep 2, 2024, 03:56
Francisco J. Esteva: The critical role of regular screenings in improving breast cancer outcomes
Insight
Sep 2, 2024, 03:50
National Cancer Society Malaysia is one of the proud recipients of the Home Away From Home grant
Insight
Sep 2, 2024, 03:41
FDA Grants Zongertinib Breakthrough Therapy Designation in HER2-Mutant NSCLC
Insight
Sep 2, 2024, 03:14
Othman Al-Sawaf: Surrogacy of endpoints in 1L CLL trials